Ardelyx (ARDX) Equity Ratio (2013 - 2026)

Ardelyx (ARDX) reported Equity Ratio of 0.29 for Q1 2026, down 17.05% on a YoY basis from 0.36 in Q1 2025, and down 11.49% quarter-over-quarter from 0.33 in Q4 2025.

Ardelyx (ARDX) Equity Ratio (2013 - 2026) Analysis & Trends

Ardelyx has reported Equity Ratio for 14 years, with the latest figure at 0.29 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 17.05% year-over-year to 0.29; the trailing twelve-month figure through Mar 2026 stood at 0.29 (down 17.05% YoY), and the FY2025 full-year result was 0.33, down 16.31% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.29, down from 0.33 in the prior quarter.
  • The five-year high for Equity Ratio was 0.66 in Q3 2023, with the low at 0.29 in Q1 2026.
  • Historically, Equity Ratio has averaged 0.44 across 5 years, with a median of 0.43 in 2024.
  • Annual changes were most pronounced in 2023 — Equity Ratio jumped 44.69% — and 2024, when it sank 34.86%.
  • Ardelyx's Equity Ratio stood at 0.52 in 2022, then increased by 8.36% to 0.56 in 2023, then slipped by 29.06% to 0.4 in 2024, then dropped by 16.31% to 0.33 in 2025, then retreated by 11.49% to 0.29 in 2026.
  • The last three Equity Ratio figures came in at 0.29 (Q1 2026), 0.33 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 0.29

Historic Data

Download Data
DateValue
Mar 31, 2026 0.29
Dec 31, 2025 0.33
Sep 30, 2025 0.32
Jun 30, 2025 0.30
Mar 31, 2025 0.36
Dec 31, 2024 0.40
Sep 30, 2024 0.43
Jun 30, 2024 0.43
Mar 31, 2024 0.44
Dec 31, 2023 0.56
Sep 30, 2023 0.66
Jun 30, 2023 0.58
Mar 31, 2023 0.58
Dec 31, 2022 0.52
Sep 30, 2022 0.46
Jun 30, 2022 0.40
Mar 31, 2022 0.50
Dec 31, 2021 0.55
Sep 30, 2021 0.48
Jun 30, 2021 0.57